Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes

Journal of Biotechnology

Volumn 44, Issue 1-3, 1996, Pages 83-89

  McKenna, T St C ^a   Rieder, E ^a   Lubroth, J ^a   Burrage, T ^a   Baxt, B ^a   Mason, P W ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

Chimera; Foot and mouth disease virus; Genetically engineered virus; Vaccine; Virus host binding

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; DISEASE CONTROL; DISEASES; GENETIC ENGINEERING; VIRUSES;

CHIMERA; EPITOPES; FOOT AND MOUTH DISEASE VIRUS; PROTECTIVE IMMUNITY; VIRUS HOST BINDING;

VACCINES;

EPITOPE; FOOT AND MOUTH DISEASE VACCINE;

CONFERENCE PAPER; DRUG SAFETY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IMMUNE RESPONSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VACCINATION; VIRUS CELL INTERACTION;

EID: 0030047687     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1656(95)00090-9     Document Type: Conference Paper

References (31)

1. Acharya, R., Fry, E., Stuart, D., Fox, D., Rowlands, D. and Brown, F. (1989) The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337, 709-713.
2. Baxt, B. and Becker, Y. (1990) The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 4, 73-83.
3. Beck, E. and Strohmaier, K. (1987) Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. J. Virol. 61, 1621-1629.
4. Bittle, J.L., Houghten, R.A., Alexander, H., Shinnick, T.M., Sutcliffe, J.G., Lerner, R.A., Rowlands, D.J. and Brown, F. (1982) Protection against foot and mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298, 30-33.
5. Clarke, B.E., Newton, S.E., Carroll, A.R., Francis, M.J., Appleyard, G., Syred, A.D., Highfield, P.E., Rowlands, D.J. and Brown, F. (1987) Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330, 381-384.
6. Crowther, J.R., Farias, S., Carpenter, W.C. and Samuel, A.R. (1993) Identification of a fifth neutralizable site on type O foot-and-mouth disease virus following characterization of single and quintuple monoclonal antibody escape mutants. J. Gen. Virol. 74, 1547-1553.
7. DiMarchi, R., Brooke, G., Gale, C., Cranknell, V., Doel, T. and Mowat, N. (1986) Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 132, 639-641.
8. Domingo, E., Mateu, M.G., Martínez, M.A., Dopazo, J., Moya, A. and Sobino, F. (1990) Genetic variability and antigenic diversity of foot-and-mouth disease virus. In: Kurstak, E., Marusyk, R.G., Murphy, F.A. and Van Regenmortel, M.H.V. (eds.), Applied Virology Research, Vol. 2. Virus Variability, Epidemiology and Control. Plemun Press Corp., New York, pp. 233-266.
9. Fox, G., Parry, N.R., Barnett, P.V., McGinn, B., Rowlands, D. and Brown, F. (1989) The cell attachment site on foot-and-mouth disease virus includes the sequence RGD (arginineglycine-aspartic acid). J. Gen. Virol. 70, 625-637.
10. Francis, M.J., Hastings, G.Z., Brown, F., McDermed, J., Lu, Y.-A. and Tam, J.P. (1991) Immunological evaluation of the multiple antigen peptide (MAP) system using the major immunogenic site of foot-and-mouth disease virus. Immunology 73, 249-254.
11. Gebauer, F., De La Torre, J.C., Gomes, I., Mateu, M.G., Barahona, H., Tiraboschi, B., Bergmann, I., Augé De Mello, P. and Domingo, E. (1988) Rapid selection of genetic and antigenic variants of foot-and-mouth disease virus during persistence in cattle. J. Virol. 62, 2041-2049.
12. Glass, E.J. and Millar, P. (1994) Induction of effective cross-reactive immunity to FMDV peptides is critically dependent upon specific MHC-peptide-T cell interactions. Immunology 82, 1-8.
13. Glass, E.J., Oliver, R.A., Collen, T., Doel, T.R., Dimarchi, R. and Spooner, R.L. (1991) MHC class II restricted recognition of FMDV peptides by bovine T cells. Immunology 74, 594-599.
14. Kit, M., Kit, S., Little, S.P., DiMarchi, R.D. and Gale, C. (1991) Bovine herpesvirus-1 (infectious bovine rhinotracheitis virus)-based viral vector which expresses foot-and-mouth disease epitopes. Vaccine 9, 564-572.
15. Kitson, J.D.A., Burke, K.L., Pullen, L.A., Belsham, G.J. and Almond, J.W. (1991) chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs. J. Virol. 65, 3068-3075.
16. Kleid, D.G., Yansura, D., Small, B., Dowbenko, D., Moore, D.M., Grubman, M.J., McKercher, P.D., Morgan, D.O., Robertson, B.H. and Bachrach, H.L. (1981) Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214, 1125-1129.
17. Krebs, O., Ahl, R., Straub, O.C. and Marquardt, O. (1993) Amino acid changes outside the G-H loop of capsid protein VP1 of type O foot-and-mouth disease virus confer resistance to neutralization by antipeptide G-H serum. Vaccine 11, 359-362.
18. Lea, S., Hernández, J., Blakemore, W., Brocchi, E., Curry, S., Domingo, E., Fry, E., Abu-Ghazaleh, R., King, A., Newman, J., Stuart, D. and Mateu, M.G. (1994) The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2, 123-139.
19. Logan, D., Abu-Ghazaleh, R., Blakemore, W., Curry, S., Jackson, T., King, A., Lea, S., Lewis, R., Newman, J., Parry, N., Rowlands, D., Stuart, D. and Fry, E. (1993) Structure of the major immunogenic site on foot-and-mouth disease virus. Nature 362, 566-568.
20. Mason, P.W., Rieder, E. and Baxt, B. (1994) RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA 91, 1932-1936.
21. Mateu, M.G., Camarero, J.A., Giralt, E., Andreu, D. and Domingo, E. (1995) Direct evaluation of the immunodominance of a major antigenic site of foot-and-mouth disease virus in a natural host. Virology 206, 298-306.
22. McCullough, K.C., De Simone, F., Brocchi, E., Capucchi, L., Crowther, J.R. and Kihm, U. (1992) Protective immune response against foot-and-mouth disease. J. Virol. 66, 1835-1840.
23. McKenna, T.St.C., Lubroth, J., Rieder, E., Baxt, B. and Mason, P.W. (1995) Receptor binding-site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD. J. Virol. 69, in press.
24. Mulcahy, G., Gale, C., Robertson, P., Iyisan, S., DiMarchi, R.D. and Doel, T.R. (1990) Isotype responses of infected, virusvaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus. Vaccine 8, 249-256.
25. Mulcahy, G., Pullen, L.A., Gale, C., DiMarchi, R.D. and Doel, T.R. (1991) Mouse protection test as a predictor of the protective capacity of synthetic foot-and-mouth disease vaccines. Vaccine 9, 19-24.
26. Mulcahy, G., Reid, E., DiMarchi, R.D., Gale, C. and Doel, T.R. (1992) Maturation of functional antibody affinity in animals immunised with synthetic foot-and-mouth disease virus. Res. Vet. Sci. 52, 133-140.
27. Parry, N., Fox, G., Rowlands, D., Brown, F., Fry, E., Acharya, R., Logan, D. and Stuart, D. (1990) Structural and serological evidence for a novel mechanisms of antigenic variation in foot-and-mouth disease virus. Nature 347, 569-572.
28. Pfaff, E., Mussgay, M., Bohm, H.O., Schultz, G.E. and Schaller, H. (1982) Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO J. 1, 869-874.
29. Rieder, E., Bunch, T., Brown, F. and Mason, P.W. (1993) Genetically engineered foot-and-mouth disease virus with poly(C) tracts of two nucleotides are virulent in mice. J. Virol. 67, 5139-5145.
30. Rieder, E., Baxt, B. and Mason, P.W. (1994) Chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protect swine against more than one serotype of FMDV, J. Virol. 68, 7092-7098.
31. Usha, R., Rohll, J.B., Spall, V.E., Shanks, M., Maule, A.J., Johnson, J.E. and Lomonossoff, G.P. (1993) Expression of an animal virus antigenic site on the surface of a plant virus particle. Virology 197, 366-374.